Vuno Inc

Chart & Performance

D1W1MN

P/E

—

P/S

2.60

EPS

—

Div Yield, %

—

Shrs. gr., 5y

11.58%

Rev. gr., 5y

94.34%

Revenues

34.85b

+34.71%

Net income

-5.78b

L-55.59%

CFO

-4.68b

L-56.93%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Vuno Inc. specializes in developing artificial intelligence solutions for the medical industry. The company's AI-driven offerings are designed to analyze diverse medical data, providing crucial assistance in diagnosing various diseases. Its comprehensive product suite includes BoneAge, an AI software for assessing bone age; DeepBrain, a quantitative brain parcellation tool for analyzing neurodegenerative and other neurological conditions; an AI-powered diagnostic support system for detecting abnormalities in chest X-rays; Fundus AI, an AI-based screening solution for retinal irregularities; and LungCT AI, which focuses on detecting and reporting pulmonary lung nodules. Established in 2014, the company is headquartered in Seoul, South Korea.

URL

https://www.vuno.co/

IPO date

Feb 26, 2021

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title KRW in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY
Title KRW in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT